Integer Holdings (ITGR) Stock Forecast & Price Target

Integer Holdings is expected to continue to see strong growth in their Cardio & Vascular product line and a steady increase in their Cardiac Rhythm Management & Neuromodulation segment, with a projected year-over-year increase of 1% and 3%, respectively. However, their earnings were slightly lower than expected due to a divestiture, but this does not affect the overall positive outlook for the company going forward. While the pending transaction with KKR may have an impact on the stock in the short term, the long-term prospects for Integer Holdings remain strong thanks to their diversified product portfolio and strong presence in the medical device industry.

Integer Holdings is expected to see lower earnings and revenues in 2026 as a result of lower gross margins and higher overhead costs stemming from recent operational investments. The company also recently lowered its full-year guidance due to customer forecast revisions and other risk adjustments, but management maintains that the core market remains strong. While the company's stock has dropped following the reduced guidance, analysts believe that the company has a durable franchise and see the lower guidance as a one-time event.